Systematic review: the diagnosis and staging of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis

A new composite model including metabolic syndrome, alanine aminotransferase and cytokeratin-18 for the diagnosis of non-alcoholic steatohepatitis in morbidly obese patients

(2010) R. Anty et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Meta-analysis: Natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity

(2010) Giovanni Musso et al.   ANNALS OF MEDICINE

Validation of the BARD scoring system in Polish patients with nonalcoholic fatty liver disease (NAFLD)

(2010) Joanna Raszeja-Wyszomirska et al.   BMC GASTROENTEROLOGY

Nine-year incident diabetes is predicted by fatty liver indices: the French D.E.S.I.R. study

(2010) Beverley Balkau et al.   BMC GASTROENTEROLOGY

Transient elastography for the diagnosis of liver fibrosis

(2010) Victor de Lédinghen et al.   Expert Review of Medical Devices

Enhanced liver fibrosis test can predict clinical outcomes in patients with chronic liver disease

(2010) J. Parkes et al.   GUT

Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease

(2010) S. McPherson et al.   GUT

Liver enzymes, nonalcoholic fatty liver disease, and incident cardiovascular disease: A narrative review and clinical perspective of prospective data

(2010) Nazim Ghouri et al.   HEPATOLOGY

Corrections: Long-term mortality in nonalcoholic fatty liver disease: Is liver histology of any prognostic significance?

(2010) Paul Angulo   HEPATOLOGY

Clinical, laboratory and histological associations in adults with nonalcoholic fatty liver disease

(2010) Brent A. Neuschwander-Tetri et al.   HEPATOLOGY

The association of genetic variability in patatin-like phospholipase domain-containing protein 3 (PNPLA3) with histological severity of nonalcoholic fatty liver disease

(2010) Yaron Rotman et al.   HEPATOLOGY

Comparison of NAFLD fibrosis score and BARD score in predicting fibrosis in nonalcoholic fatty liver disease

(2010) Gabriela Ruffillo et al.   JOURNAL OF HEPATOLOGY

Feasibility of liver transient elastography with FibroScan® using a new probe for obese patients

(2010) Victor De Lédinghen et al.   LIVER INTERNATIONAL

Controlled Attenuation Parameter (CAP): A Novel VCTE™ Guided Ultrasonic Attenuation Measurement for the Evaluation of Hepatic Steatosis: Preliminary Study and Validation in a Cohort of Patients with Chronic Liver Disease from Various Causes

(2010) Magali Sasso et al.   ULTRASOUND IN MEDICINE AND BIOLOGY

Systematic review: caspase-cleaved fragments of cytokeratin 18 - the promises and challenges of a biomarker for chronic liver disease

(2009) Y. YILMAZ   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Comparison of Noninvasive Markers of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease

(2009) Amy G. Shah et al.   Clinical Gastroenterology and Hepatology

Non-alcoholic fatty liver disease pathogenesis: The present and the future

(2009) S. Petta et al.   DIGESTIVE AND LIVER DISEASE

Could inflammatory markers help diagnose nonalcoholic steatohepatitis?

(2009) Giovanni Tarantino et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

Applicability of BARD score to Japanese patients with NAFLD

(2009) H Fujii et al.   GUT

Hepatocellular carcinomas in patients with metabolic syndrome often develop without significant liver fibrosis: A pathological analysis

(2009) Valérie Paradis et al.   HEPATOLOGY

Ultrasonographic hepatic steatosis increases prediction of mortality risk from elevated serum gamma-glutamyl transpeptidase levels

(2009) Robin Haring et al.   HEPATOLOGY

Fatty liver is associated with insulin resistance, risk of coronary heart disease, and early atherosclerosis in a large European population

(2009) Amalia Gastaldelli et al.   HEPATOLOGY

Cytokeratin-18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: A multicenter validation study

(2009) Ariel E. Feldstein et al.   HEPATOLOGY

Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease

(2009) Vincent Wai-Sun Wong et al.   HEPATOLOGY

Diagnostic value of a group of biochemical markers of liver fibrosis in patients with non-alcoholic steatohepatitis

(2009) C. Rinaldi A. LESMANA et al.   Journal of Digestive Diseases

Noninvasive laboratory tests proposed for predicting cirrhosis in patients with chronic hepatitis C are also useful in patients with non-alcoholic steatohepatitis

(2009) Hideki Fujii et al.   JOURNAL OF GASTROENTEROLOGY

Non-invasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance

(2009) Nina F. Schwenzer et al.   JOURNAL OF HEPATOLOGY

Serum adipokine levels predictive of liver injury in non-alcoholic fatty liver disease

(2009) Maud Lemoine et al.   LIVER INTERNATIONAL

Endocrine and liver interaction: the role of endocrine pathways in NASH

(2009) Paola Loria et al.   Nature Reviews Gastroenterology & Hepatology

Adipokine Serum Levels Are Related to Liver Histology in Severely Obese Patients Undergoing Bariatric Surgery

(2009) Marianna Argentou et al.   OBESITY SURGERY

Pathogenesis of non-alcoholic fatty liver disease

(2009) J. K. Dowman et al.   QJM-AN INTERNATIONAL JOURNAL OF MEDICINE

Review article: diagnosis and treatment of non-alcoholic fatty liver disease

(2008) M. K. OH et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Hepatic Steatosis and Subclinical Cardiovascular Disease in a Cohort Enriched for Type 2 Diabetes: The Diabetes Heart Study

(2008) Ryan L. McKimmie et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Increased Hepatic and Circulating Interleukin-6 Levels in Human Nonalcoholic Steatohepatitis

(2008) Anna Wieckowska et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Plasma Pentraxin3 is a Novel Marker for Nonalcoholic Steatohepatitis (NASH)

(2008) Masato Yoneda et al.   BMC GASTROENTEROLOGY

Cytokeratin 18 Fragment Levels as a Noninvasive Biomarker for Nonalcoholic Steatohepatitis in Bariatric Surgery Patients

(2008) Dima L. Diab et al.   Clinical Gastroenterology and Hepatology

Non-alcoholic fatty liver disease: an overview of prevalence, diagnosis, pathogenesis and treatment considerations

(2008) David Preiss et al.   CLINICAL SCIENCE

Diagnostic Value of Serum Prolidase Enzyme Activity to Predict the Liver Histological Lesions in Non-alcoholic Fatty Liver Disease: A Surrogate Marker to Distinguish Steatohepatitis from Simple Steatosis

(2008) Huseyin Kayadibi et al.   DIGESTIVE DISEASES AND SCIENCES

Causes and Metabolic Consequences of Fatty Liver

(2008) Norbert Stefan et al.   ENDOCRINE REVIEWS

Transient elastography (FibroScan)

(2008) V. de Lédinghen et al.   GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE

Magnetic Resonance Elastography for the Noninvasive Staging of Liver Fibrosis

(2008) Laurent Huwart et al.   GASTROENTEROLOGY

Diagnosis and Therapy of Nonalcoholic Steatohepatitis

(2008) Dawn M. Torres et al.   GASTROENTEROLOGY

Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease

(2008) S A Harrison et al.   GUT

Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: A role for insulin resistance and diabetes

(2008) Anna Ludovica Fracanzani et al.   HEPATOLOGY

Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Selected practical issues in their evaluation and management

(2008) Raj Vuppalanchi et al.   HEPATOLOGY

Role of hepatic iron in non-alcoholic steatohepatitis

(2008) Yoshio Sumida et al.   HEPATOLOGY RESEARCH

Increased overall mortality and liver-related mortality in non-alcoholic fatty liver disease

(2008) Janus P. Ong et al.   JOURNAL OF HEPATOLOGY

Non-alcoholic fatty liver disease: The mist gradually clears

(2008) Nimantha Mark Wilfred de Alwis et al.   JOURNAL OF HEPATOLOGY

Comparison of blood tests for liver fibrosis specific or not to NAFLD

(2008) Paul Calès et al.   JOURNAL OF HEPATOLOGY

Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease

(2008) Stefano Romeo et al.   NATURE GENETICS

The Utility of the “NAFLD Fibrosis Score” in Morbidly Obese Subjects with NAFLD

(2008) Kamran Qureshi et al.   OBESITY SURGERY

A Novel Diagnostic Biomarker Panel for Obesity-related Nonalcoholic Steatohepatitis (NASH)

(2008) Zobair M. Younossi et al.   OBESITY SURGERY

Diagnosis of Nonalcoholic Fatty Liver Disease: Invasive versus Noninvasive

(2008) Anna Wieckowska et al.   SEMINARS IN LIVER DISEASE